Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers [Phase 1]
Phase 1 safety and tolerability update for Metacavir enteric-coated capsules in healthy adult volunteers, with Chronic Hepatitis B as the re…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States [Phase 2]
This clinical trial update confirms completion of a Phase 2 rollover/continued access protocol for emtricitabine/tenofovir disoproxil fumara…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y [Phase 3]
A completed Phase 3 trial evaluated the immunogenicity and safety of an adjuvanted hepatitis B vaccine compared with Engerix-B in adults who…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]
Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers [Phase 1]
Phase 1 trial assessing persistence of cellular and humoral immune responses after vaccination with GlaxoSmithKline's Hepatitis B vaccine ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients [Phase 1]
A Phase 1 trial evaluating RO7020322 in healthy participants and chronic hepatitis B patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
Clinical trial update indicating the Special Drug Use Investigation of lamivudine (ZEFIX) tablets for chronic hepatitis B with HBV-related l…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age [Phase 3]
Phase 3 study evaluating immunogenicity, safety, and tolerability of a fully liquid pentavalent vaccine (DTwP-Hib-HepB) in infants aged 6-8 …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France
The ANRS Emerging Infectious Diseases-sponsored study NCT02566148 has completed and examines HIV infection and chronic hepatitis B among Afr…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years [NA]
A clinical trial assessing immune response to a Hepatitis B booster given 20-23 years after initial vaccination has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg [Phase 1]
Phase 1 study evaluating a hepatitis B vaccine in chronic hepatitis B patients with low serum HBsAg; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy [Phase 4]
Phase 4 trial assessing serovaccination and tenofovir during pregnancy to prevent vertical transmission of hepatitis B.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women
This clinical trial update indicates that the study on Hepatitis B virus vertical transmission from HIV-HBV co-infected women has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants [Phase 3]
Phase 3 trial comparing a DTaP-IPV-HepB-PRP-T vaccine with a DTaP-IPV-PRP-T vaccine plus Hep B in Hep B-primed infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease [NA]
A terminated observational trial assessed the prevalence and clinical course of chronic hepatitis B infection in patients with inflammatory …
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy
This clinical trial update notes the completion of a registry study of patients with chronic hepatitis B receiving nucleotide therapy, spons…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts [Phase 4]
A Phase 4 trial evaluating hepatitis B vaccination in HIV-infected adults with low CD4 counts has completed, according to the clinical trial…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Hepatitis B Vaccination in HIV-infected Adults [Phase 4]
A Phase 4 clinical trial assessing Hepatitis B vaccination in HIV-infected adults has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine [Phase 2]
Phase 2 open-label study assessing safety and immunogenicity of HEPLISAV hepatitis B vaccine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. [Phase 4]
A Phase 4 study evaluating Pegasys (peginterferon alfa-2a) for chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. [Phase 2]
Phase 2 feasibility study of GSK's GSK2202083A vaccine in healthy infants at 3, 5, and 11 months was terminated, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e Antigen [Phase 3]
Phase 3 trial comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in HBeAg-positive chronic hepatitis B; study comp…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen [Phase 3]
A Phase 3 trial comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in people with chronic hepatitis B who are HBeA…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…